InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NEKTAR THERAPEUTICS

NKTR Clue Score14
United States Fiscal year ends December CIK 0000906709 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
Jonathan Zalevsky
30 Jun 2026
Chief R&D Officer
Sold on a plan
5,681
$70.00
$397.67K
Howard W Robin
17 Jun 2026
President & CEO
Sold on a plan
4,500
$61.65
$277.43K
Howard W Robin
17 Jun 2026
President & CEO
Sold on a plan
5,500
$60.81
$334.46K
Howard W Robin
16 Jun 2026
President & CEO
Sold on a plan
4,697
$60.71
$285.15K
Howard W Robin
16 Jun 2026
President & CEO
Sold on a plan
5,303
$59.97
$318.02K
Jonathan Zalevsky
15 Jun 2026
Chief R&D Officer
Sold on a plan
5,538
$60.71
$336.21K
Jonathan Zalevsky
20 Jan 2026
Chief R&D Officer
Sold on a plan
3,867
$35.67
$137.94K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
1,210
$48.18
$58.30K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
2,156
$47.49
$102.39K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
1,200
$46.41
$55.69K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
2,100
$45.16
$94.84K
Howard W Robin
5 Sep 2025
President & CEO
Sold on a plan
1,136
$39.89
$45.32K
Howard W Robin
5 Sep 2025
President & CEO
Sold on a plan
2,226
$38.82
$86.41K
Howard W Robin
5 Sep 2025
President & CEO
Sold on a plan
3,304
$37.87
$125.12K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
1,134
$35.80
$40.60K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
613
$34.40
$21.09K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
1,496
$33.54
$50.18K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
1,923
$32.37
$62.25K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
307
$35.69
$10.96K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
189
$34.41
$6.50K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
432
$33.60
$14.52K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
793
$32.43
$25.72K
Howard W Robin
2 Sep 2025
President & CEO
Sold on a plan
1,500
$30.16
$45.24K
Jonathan Zalevsky
2 Sep 2025
Chief R&D Officer
Sold on a plan
485
$30.10
$14.60K
Robert Chess
14 Jun 2024
Director
Sold on a plan
19,500
$1.20
$23.40K
Roy A Whitfield
14 Jun 2023
Director
Sold on a plan
30,000
$0.57
$17.10K
Robert Chess
22 Sep 2022
Director
Sold on a plan
10,200
$0.67
$6.83K
Showing 250 of 382 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 431
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 122
Sales at will 212
Transactions with no price 0
Shares from compensation/vesting 10,057,054
Sales filed before the plan box existed 165
History held since 7 Nov 2006